drugset / Trial / NCT05925114

Safety and Efficacy Study of S-309309 in Obese Adults

NCT05925114 ↗

Phase 2 Completed 365 enrolled Shionogi
RandomizedParallel-groupDouble-blindTreatment

Summary

The primary objective of this study is to understand the efficacy of S-309309 on the body weight of obese adults.

Timeline

Start
2023-06-21
Primary completion
2024-04-15
Completion
2024-05-17

Drugs

EvaluationDrugModalityDoseRoute
Subject S-309309 Unknown — Oral

Indications